Skip to main content
Signal8

EIDE ROBERT J

SEC insider (Form 3/4/5 filer). CIK 0001181955. 10% Owner at Matinas BioPharma Holdings, Inc. (MTNB). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 8, 2025. Located in NEW YORK, NY.

Companies EIDE ROBERT J has filed insider reports for

  • Matinas BioPharma Holdings, Inc. (MTNB): 10% Owner
EIDE ROBERT J profile photo

EIDE ROBERT J

CIK: 0001181955

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Matinas BioPharma Holdings, Inc. logo
MTNB

Matinas BioPharma Holdings, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Matinas BioPharma Holdings, Inc. logo
    MTNB

    Matinas BioPharma Holdings, Inc.

    Apr 8, 2025
    Purchase

    Series C Convertible Preferred Stock

    Indirect
    492 shares at avg. $1000.00-
  • Matinas BioPharma Holdings, Inc. logo
    MTNB

    Matinas BioPharma Holdings, Inc.

    Apr 8, 2025
    Purchase

    Warrants

    Indirect
    1.7M shares-

1-2 of 2